Fine Foods & Pharmaceuticals NTM SpA
MIL:FF
Fine Foods & Pharmaceuticals NTM SpA
MIL:FF
Price:
8.2
EUR
-1.68%
Market Closed
Market Cap:
€180.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Fine Foods & Pharmaceuticals NTM SpA
MIL:FF
|
IT |
|
Hakuhodo DY Holdings Inc
OTC:HKUOF
|
JP |
|
O
|
Oncozenge AB
STO:ONCOZ
|
SE |
|
Ignitis Grupe AB
LSE:IGN
|
LT |
|
URU Metals Ltd
LSE:URU
|
CA |
Balance Sheet
Balance Sheet Decomposition
Fine Foods & Pharmaceuticals NTM SpA
Fine Foods & Pharmaceuticals NTM SpA
Balance Sheet Decomposition is not available for
Fine Foods & Pharmaceuticals NTM SpA
Fine Foods & Pharmaceuticals NTM SpA
Balance Sheet
Fine Foods & Pharmaceuticals NTM SpA
Fine Foods & Pharmaceuticals NTM SpA
Currency: EUR
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
101
|
101
|
75
|
3
|
3
|
17
|
10
|
19
|
19
|
|
| Cash |
0
|
0
|
75
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
101
|
101
|
0
|
3
|
3
|
17
|
10
|
19
|
19
|
|
| Short-Term Investments |
0
|
0
|
0
|
72
|
72
|
78
|
67
|
4
|
0
|
|
| Total Receivables |
0
|
0
|
27
|
17
|
13
|
32
|
45
|
44
|
43
|
|
| Accounts Receivables |
0
|
0
|
22
|
17
|
13
|
29
|
39
|
38
|
38
|
|
| Other Receivables |
0
|
0
|
5
|
0
|
0
|
2
|
6
|
6
|
6
|
|
| Inventory |
0
|
0
|
22
|
22
|
20
|
35
|
40
|
42
|
32
|
|
| Other Current Assets |
0
|
0
|
0
|
2
|
3
|
10
|
2
|
2
|
2
|
|
| Total Current Assets |
101
|
101
|
124
|
117
|
111
|
172
|
165
|
111
|
96
|
|
| PP&E Net |
0
|
0
|
79
|
90
|
94
|
109
|
109
|
110
|
129
|
|
| PP&E Gross |
0
|
0
|
79
|
90
|
94
|
109
|
109
|
110
|
129
|
|
| Accumulated Depreciation |
0
|
0
|
66
|
75
|
85
|
108
|
115
|
127
|
140
|
|
| Intangible Assets |
1
|
0
|
4
|
1
|
2
|
3
|
2
|
2
|
2
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
16
|
16
|
12
|
12
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
1
|
2
|
4
|
8
|
7
|
4
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
16
|
16
|
12
|
12
|
|
| Total Assets |
102
N/A
|
102
0%
|
207
+103%
|
210
+1%
|
207
-1%
|
303
+46%
|
300
-1%
|
242
-19%
|
243
+0%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
0
|
0
|
24
|
21
|
23
|
33
|
33
|
32
|
37
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
9
|
11
|
13
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
3
|
3
|
3
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
6
|
4
|
2
|
49
|
37
|
55
|
19
|
|
| Other Current Liabilities |
0
|
0
|
5
|
31
|
21
|
23
|
1
|
3
|
2
|
|
| Total Current Liabilities |
0
|
0
|
34
|
56
|
49
|
110
|
84
|
101
|
71
|
|
| Long-Term Debt |
0
|
0
|
23
|
21
|
16
|
42
|
80
|
11
|
36
|
|
| Deferred Income Tax |
0
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
1
|
1
|
1
|
3
|
2
|
2
|
4
|
|
| Total Liabilities |
0
N/A
|
0
+41%
|
58
+35 953%
|
79
+37%
|
66
-16%
|
156
+134%
|
167
+7%
|
115
-31%
|
111
-4%
|
|
| Equity | ||||||||||
| Common Stock |
10
|
10
|
23
|
23
|
23
|
23
|
23
|
23
|
23
|
|
| Retained Earnings |
0
|
0
|
13
|
108
|
118
|
131
|
33
|
27
|
32
|
|
| Additional Paid In Capital |
92
|
92
|
87
|
0
|
0
|
0
|
87
|
87
|
87
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
14
|
14
|
14
|
|
| Other Equity |
0
|
0
|
27
|
0
|
0
|
7
|
5
|
5
|
5
|
|
| Total Equity |
102
N/A
|
102
0%
|
149
+47%
|
131
-12%
|
141
+8%
|
147
+4%
|
133
-9%
|
127
-5%
|
132
+4%
|
|
| Total Liabilities & Equity |
102
N/A
|
102
0%
|
207
+103%
|
210
+1%
|
207
-1%
|
303
+46%
|
300
-1%
|
242
-19%
|
243
+0%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
10
|
10
|
23
|
23
|
23
|
24
|
25
|
24
|
24
|
|
Switch to:
Switch to:
See Also
Discover More
